DDX41 and acute myeloid leukemia: Similarly, in patients treated with intensive chemotherapy, the presence of mutated DDX41 in MDS/AML was reported to confer a favorable prognosis with longer OS compared to DDX41 wild-type AML and other favorable-risk AML cases [161,162,163].